跳至主要内容
临床试验/IRCT20141209020258N167
IRCT20141209020258N167招募中3 期

Comparison of the effect of?? ?Labetalol and Remifentanil and Dexmedetomidine in control of ?bleeding during Craniotomy

Vice chancellor for research, Arak University Of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Age 18 to 75 years
  • ASA Class One and Two
  • No coagulation disorders
  • No history of cardiovascular disease
  • Proper control of blood pressure
  • Absence of pregnancy
  • Not addicted to opioids
  • Body mass index more than 35
  • Candidate patients for craniotomy

排除标准

  • Dissatisfaction
  • Existence of allergy to the studied drugs
  • Platelet count less than 150 thousand
  • Family history of thromboembolism

研究者

发起方
Vice chancellor for research, Arak University Of Medical Sciences

相似试验